Literature DB >> 16506039

Morbidity of parotid gland surgery: results 1 year post-operative.

J Alexander de Ru1, Peter Paul G van Benthem, Gerrit Jan Hordijk.   

Abstract

Patients operated on for parotid gland tumours were evaluated prospectively to study morbidity after this procedure. Nowadays, major complications such as recurrence of tumour and permanent facial nerve paresis are rare after primary surgery. Therefore, this study especially takes minor complications such as Frey's syndrome and sensory deficits into account. The study documents morbidity in 45 patients who completed a 1 year follow-up. Among those with primary benign tumours, we found no recurrences and no permanent paresis, nor did starch-iodine testing reveal any cases of Frey's syndrome. However, two patients who had previously been operated on multiple times did test positive for Frey's syndrome, as did two others after surgery for malignancy. Furthermore, we found that patients whose posterior branch of the great auricular nerve was sacrificed had a larger area of sensory deficit than those whose nerve was preserved. We conclude that the morbidity of parotid gland surgery can be reduced further by giving minor complications more attention.

Entities:  

Mesh:

Year:  2006        PMID: 16506039     DOI: 10.1007/s00405-006-0016-z

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  20 in total

1.  Temporoparietal fascia flaps and superficial musculoaponeurotic system plication in parotid surgery reduces Frey's syndrome.

Authors:  Luc Cesteleyn; Joseph Helman; Steven King; Gaétan Van de Vyvere
Journal:  J Oral Maxillofac Surg       Date:  2002-11       Impact factor: 1.895

2.  Randomized prospective study of the validity of the great auricular nerve preservation in parotidectomy.

Authors:  Mauro Becker Martins Vieira; Amélio Ferreira Maia; Jaime Carlos Ribeiro
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2002-10

3.  Accidental full thickness burn of the ear lobe following division of the great auricular nerve at parotidectomy.

Authors:  A M Brown; M J Wake
Journal:  Br J Oral Maxillofac Surg       Date:  1990-06       Impact factor: 1.651

4.  Facial nerve grading system.

Authors:  J W House; D E Brackmann
Journal:  Otolaryngol Head Neck Surg       Date:  1985-04       Impact factor: 3.497

5.  Unusual variant of a metastasizing malignant mixed tumor of the parotid gland.

Authors:  A J Minić
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1993-09

6.  Frey's syndrome after parotidectomy: a retrospective and prospective analysis.

Authors:  T E Linder; A Huber; S Schmid
Journal:  Laryngoscope       Date:  1997-11       Impact factor: 3.325

7.  Metastasizing mixed tumor of the parotid gland: a rare tumor with unusually rapid progression in a cardiac transplant recipient.

Authors:  B A Sampson; J A Jarcho; G L Winters
Journal:  Mod Pathol       Date:  1998-11       Impact factor: 7.842

8.  A prospective controlled double-blind trial of great auricular nerve preservation at parotidectomy.

Authors:  Yau Hui; David S Y Wong; Ling-Yuen Wong; Wai-Kuen Ho; William I Wei
Journal:  Am J Surg       Date:  2003-06       Impact factor: 2.565

9.  Sternocleidomastoid muscle transfer and superficial musculoaponeurotic system plication in the prevention of Frey's syndrome.

Authors:  J D Casler; J Conley
Journal:  Laryngoscope       Date:  1991-01       Impact factor: 3.325

10.  Current management of benign parotid tumors--the role of limited superficial parotidectomy.

Authors:  Christopher J O'Brien
Journal:  Head Neck       Date:  2003-11       Impact factor: 3.147

View more
  2 in total

1.  Facial surgical incisions--role of maxillofacial surgeons.

Authors:  A Majumdar
Journal:  Ann R Coll Surg Engl       Date:  2010-04       Impact factor: 1.891

2.  Parotidectomy: the timing of post-operative complications.

Authors:  Scott E Henney; R Brown; D E Phillips
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-01       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.